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Abstract
The CRISPR-associated protein Cas9 is an RNA-guided DNA endonuclease that uses RNA:DNA 
complementarity to identify target sites for sequence-specific doublestranded DNA (dsDNA) 
cleavage1-5. In its native context, Cas9 acts on DNA substrates exclusively because both binding 
and catalysis require recognition of a short DNA sequence, the protospacer adjacent motif (PAM), 
next to and on the strand opposite the 20-nucleotide target site in dsDNA4-7. Cas9 has proven to 
be a versatile tool for genome engineering and gene regulation in many cell types and organisms8, 
but it has been thought to be incapable of targeting RNA5. Here we show that Cas9 binds with 
high affinity to single-stranded RNA (ssRNA) targets matching the Cas9-associated guide RNA 
sequence when the PAM is presented in trans as a separate DNA oligonucleotide. Furthermore, 
PAM-presenting oligonucleotides (PAMmers) stimulate site-specific endonucleolytic cleavage of 
ssRNA targets, similar to PAM-mediated stimulation of Cas9-catalyzed DNA cleavage7. Using 
specially designed PAMmers, Cas9 can be specifically directed to bind or cut RNA targets while 
avoiding corresponding DNA sequences, and we demonstrate that this strategy enables the 
isolation of a specific endogenous mRNA from cells. These results reveal a fundamental 
connection between PAM binding and substrate selection by Cas9, and highlight the utility of 
Cas9 for programmable and tagless transcript recognition.
CRISPR–Cas immune systems must discriminate between self and non-self to avoid an 
autoimmune response9. In type I and II systems, foreign DNA targets which contain 
adjacent PAM sequences are targeted for degradation, whereas potential targets in CRISPR 
loci of the host do not contain PAMs and are avoided by RNA-guided interference 
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complexes3,5,6,10. Single-molecule and bulk biochemical experiments showed that PAMs 
act both to recruit Cas9–guide RNA complexes (Cas9–gRNA) to potential target sites and to 
trigger nuclease domain activation7. Cas9 from Streptococcus pyogenes recognizes a 5’-
NGG-3’ PAM on the non-target (displaced) DNA strand4,6, suggesting that PAM 
recognition may stimulate catalysis through allosteric regulation. Moreover, the HNH 
nuclease domain of Cas9, which mediates target strand cleavage4,5, is homologous to other 
HNH domains that cleave RNA substrates11,12. Based on the observation that single-
stranded DNA (ssDNA) targets can be activated for cleavage by a separate PAMmer 
oligonucleotide7, and that similar HNH domains can cleave RNA, we wondered whether a 
similar strategy would enable Cas9 to cleave ssRNA targets in a programmable fashion (Fig. 
1a).
Using S. pyogenes Cas9 and dual-guide RNAs (Methods), we performed in vitro cleavage 
experiments using a panel of RNA and DNA targets (Fig. 1b and Extended Table 1). 
Deoxyribonucleotide-comprised PAMmers specifically activated Cas9 to cleave ssRNA 
(Fig. 1c), an effect that required a 5’-NGG-3’ or 5’-GG-3’ PAM. RNA cleavage was not 
observed using ribonucleotide-based PAMmers, suggesting that Cas9 may recognize the 
local helical geometry and/or deoxyribose moieties within the PAM. Consistent with this 
idea, dsRNA targets were not cleavable, and RNA–DNA heteroduplexes could only be 
cleaved when the non-target strand was composed of deoxyribonucleotides. Interestingly, 
we found that Cas9 cleaved the ssRNA target strand between positions 4 and 5 of the base-
paired guide RNA-target RNA hybrid (Fig. 1d), in contrast to the cleavage between 
positions 3 and 4 observed for dsDNA3-5 likely due to subtle differences in substrate 
positioning. However, we did observe a significant reduction in the pseudo-first order 
cleavage rate constant of PAMmeractivated ssRNA as compared to ssDNA7 (Extended Data 
Fig. 1).
We hypothesized that PAMmer nuclease activation would depend on the stability of the 
hybridized PAMmer–ssRNA duplex and tested this by varying PAMmer length. As 
expected, ssRNA cleavage was lost when the predicted melting temperature for the duplex 
decreased below the temperature used in our experiments (Fig. 1e). In addition, large molar 
excesses of di- or tri-deoxyribonucleotides in solution were poor activators of Cas9 cleavage 
(Extended Data Fig. 2). Collectively, these data demonstrate that hybrid substrate structures 
composed of ssRNA and deoxyribonucleotide-based PAMmers that anneal upstream of the 
RNA target sequence can be cleaved efficiently by RNA-guided Cas9.
We investigated the binding affinity of catalytically inactive (dCas9; D10A/H840A) dCas9–
gRNA for ssRNA targets with and without PAMmers using a gel mobility shift assay. 
Intriguingly, while our previous results showed that ssDNA and PAMmer-activated ssDNA 
targets are bound with indistinguishable affinity7, PAMmer-activated ssRNA targets were 
bound >500-fold tighter than ssRNA alone (Fig. 2a,b). A recent crystal structure of Cas9 
bound to a ssDNA target revealed deoxyribose-specific van der Waals interactions between 
the protein and the DNA backbone13, suggesting that energetic penalties associated with 
ssRNA binding must be attenuated by favorable compensatory binding interactions with the 
provided PAM. The equilibrium dissociation constant measured for a PAMmer–ssRNA 
substrate was within 5-fold of that for dsDNA (Fig. 2b), and this high-affinity interaction 
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again required a cognate deoxyribonucleotide-comprised 5’-GG-3’ PAM (Fig. 2a). Tight 
binding also scaled with PAMmer length (Fig. 2c), consistent with the cleavage data 
presented above.
It was known that Cas9 possesses an intrinsic affinity for RNA, but sequence specificity of 
the interaction was not explored5. Thus, to verify the programmable nature of PAMme-
rmediated ssRNA cleavage by Cas9–gRNA, we prepared three distinct guide RNAs (λ2, λ3, 
and λ4) and showed that their corresponding ssRNA targets could be efficiently cleaved 
using complementary PAMmers without any detectable cross-reactivity (Fig. 3a). This result 
indicates that complementary RNA–RNA base-pairing is critical in these reactions. 
Surprisingly, though, dCas9 programmed with the λ2 guide RNA bound all three PAMmer–
ssRNA substrates with similar affinity (Fig. 3b). This observation suggests that high-affinity 
binding in this case may not require correct base-pairing between the guide RNA and the 
ssRNA target, particularly given the compensatory role of the PAMmer.
During dsDNA targeting by Cas9–gRNA, duplex melting proceeds directionally from the 
PAM and strictly requires formation of complementary RNA–DNA base-pairs to offset the 
energetic costs associated with dsDNA unwinding7. We therefore wondered whether 
binding specificity for ssRNA substrates would be recovered using PAMmers containing 5’-
extensions that create a partially double-stranded target region requiring unwinding (Fig. 
3c). Indeed, we found that use of a 5’-extended PAMmer enabled dCas9 bearing the λ2 
guide sequence to bind sequence-selectively to the λ2 PAMmer–ssRNA target. The λ3 and 
λ4 PAMmer–ssRNA targets were not recognized (Fig. 3d and Extended Data Fig. 3), 
although we did observe a 10-fold reduction in overall ssRNA substrate binding affinity. By 
systematically varying the length of the 5’ extension, we found that PAMmers containing 2–
8 additional nucleotides upstream of the 5’-NGG-3’ offer an optimal compromise between 
gains in binding specificity and concomitant losses in binding affinity and cleavage 
efficiency (Extended Data Fig. 4).
Next we investigated whether nuclease activation by PAMmers requires base-pairing 
between the 5’-NGG-3’ and corresponding nucleotides on the ssRNA. Prior studies showed 
that DNA substrates containing a cognate PAM that is mismatched with the corresponding 
nucleotides on the target strand are cleaved as efficiently as a fully base-paired PAM4. 
Importantly, this could enable targeting of RNA while precluding binding or cleavage of 
corresponding genomic DNA sites lacking PAMs (Fig. 4a). To test this possibility, we first 
demonstrated that Cas9–gRNA cleaves PAMmer–ssRNA substrates regardless of whether or 
not the PAM is base-paired (Fig. 4b, c). When Cas9–RNA was incubated with both a 
PAMmer–ssRNA substrate and the corresponding dsDNA template containing a cognate 
PAM, both targets were cleaved. In contrast, when a dsDNA target lacking a PAM was 
incubated together with a PAMmer-ssRNA substrate bearing a mismatched 5’-NGG-3’ 
PAM, Cas9–gRNA selectively targeted the ssRNA for cleavage (Fig. 4c). The same result 
was obtained using a mismatched PAMmer with a 5’ extension (Fig. 4c), demonstrating that 
this general strategy enables the specific targeting of RNA transcripts while effectively 
eliminating any targeting of their corresponding dsDNA template loci.
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We next explored whether Cas9-mediated RNA targeting could be applied for tagless 
transcript isolation from HeLa cells (Fig. 4d). The immobilization of Cas9 on a solid-phase 
resin is described in Methods (see also Extended Data Fig. 5). As a proof of concept, we 
first isolated GAPDH mRNA from HeLa total RNA using biotinylated dCas9, gRNAs and 
PAMmers (Extended Table 2) that target four non-PAM-adjacent sequences within exons 5–
7 (Fig. 4e). We observed a substantial enrichment of GAPDH mRNA relative to a control β-
actin mRNA by Northern blot analysis, but saw no enrichment using a non-targeting gRNA 
or dCas9 alone (Fig. 4f).
We then used this approach to isolate endogenous GAPDH transcripts from HeLa cell lysate 
under physiological conditions. In initial experiments, we found that Cas9–gRNA captured 
two GAPDH-specific RNA fragments rather than the full-length mRNA (Fig. 4g). Based on 
the sizes of these bands, we hypothesized that RNA:DNA heteroduplexes formed between 
the mRNA and PAMmer were cleaved by cellular RNase H. Previous studies have shown 
that modified DNA oligonucleotides can abrogate RNase H activity14, and therefore we 
investigated whether Cas9 would tolerate chemical modifications to the PAMmer. We found 
that a wide range of modifications (locked nucleic acids, 2’-OMe and 2’-F ribose moieties) 
still enabled PAMmer-mediated nuclease activation (Extended Data Fig. 6). Importantly, by 
varying the pattern of 2’-OMe modifications in the PAMmer, we could completely eliminate 
RNase H-mediated cleavage during the pull-down and successfully isolate intact GAPDH 
mRNA (Fig. 4g,h). Interestingly, we consistently observed specific isolation of GAPDH 
mRNA in the absence of any PAMmer, albeit with lower efficiency, suggesting that Cas9–
gRNA can bind to GAPDH mRNA through direct RNA:RNA hybridization (Fig. 4f,g and 
Extended Data Fig. 7). These experiments demonstrate that RNA-guided Cas9 can be used 
to purify endogenous untagged RNA transcripts. In contrast to current oligonucleotide-
mediated RNA-capture methods, this approach works well under physiological salt 
conditions and does not require crosslinking or large sets of biotinylated probes15-17.
Here we have demonstrated the ability to re-direct the dsDNA targeting capability of 
CRISPR/Cas9 for RNA-guided ssRNA binding and/or cleavage (RCas9). Programmable 
RNA recognition and cleavage has the potential to transform the study of RNA function 
much as site-specific DNA targeting is changing the landscape of genetic and genomic 
research8 (Extended Data Fig. 8). Although certain engineered proteins such as PPR proteins 
and Pumilio/FBF (PUF) repeats show promise as platforms for sequence-specific RNA 
targeting18- 22, these strategies require re-designing the protein for every new RNA sequence 
of interest. While RNA interference has proven useful for manipulating gene regulation in 
certain organisms23, there has been a strong motivation to develop orthogonal nucleic acid-
based RNA recognition systems, such as the CRISPR/Cas Type III-B Cmr complex24-28 and 
the atypical Cas9 from Francisella novicida29,30. In contrast to these systems, the molecular 
basis for RNA recognition by RCas9 is now clear and requires only the design and synthesis 
of a matching gRNA and complementary PAMmer. The ability to recognize endogenous 
RNAs within complex mixtures with high affinity and in a programmable manner paves the 
way for direct transcript detection, analysis and manipulation without the need for 
genetically encoded affinity tags.
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METHODS
Cas9 and nucleic acid preparation
Wild-type Cas9 and catalytically inactive dCas9 (D10A/H840A) from S. pyogenes were 
purified as previously described4. crRNAs (42 nt) were either ordered synthetically 
(Integrated DNA Technologies) or transcribed in vitro with T7 polymerase using single-
stranded DNA templates, as described31. tracrRNA was transcribed in vitro and contained 
nucleotides 15–87 following the numbering scheme used previously4. λ-targeting sgRNAs 
were in vitro transcribed from linearized plasmids and contain full-length crRNA and 
tracrRNA connected via a GAAA tetraloop insertion. GAPDH mRNA-targeting sgRNAs 
were in vitro transcribed from dsDNA PCR products based on an optimized sgRNA 
design32. Target ssRNAs (55–56 nt) were in vitro transcribed using single-stranded DNA 
templates. Sequences of all nucleic acid substrates used in this study can be found in 
Extended Data Tables 1 & 2.
All RNAs were purified using 10–15% denaturing polyacrylamide gel electrophoresis 
(PAGE). crRNA–tracrRNA duplexes were prepared by mixing equimolar concentrations of 
each RNA in hybridization buffer (20 mM Tris-HCl, pH 7.5, 100 mM KCl, 5 mM MgCl2), 
heating to 95 °C for 30 s and slow cooling. Fully double-stranded DNA/RNA substrates 
(substrates 1, 8–10 in Fig. 1 and substrates 1–2 in Fig. 4) were prepared by mixing 
equimolar concentrations of each nucleic acid strand in hybridization buffer, heating to 95 
°C for 30 s, and slow cooling. RNA, DNA, and chemically modified PAMmers were 
synthesized commercially (Intergrated DNA Technologies). DNA and RNA substrates were 
5’-radiolabeled using [γ-32P]-ATP (PerkinElmer) and T4 polynucleotide kinase (New 
England Biolabs). dsDNA and dsRNA substrates (Fig. 1c, 4c) were 5’-radiolabeled on both 
strands, whereas only the target ssRNA was 5’-radiolabeled in other experiments.
Cleavage assays
Cas9–gRNA complexes were reconstituted before cleavage experiments by incubating Cas9 
and the crRNA–tracrRNA duplex for 10 min at 37 °C in reaction buffer (20 mM Tris-HCl, 
pH 7.5, 75 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 5% glycerol). Cleavage 
reactions were conducted at 37 °C and contained ~1 nM 5′-radiolabeled target substrate, 100 
nM Cas9–RNA, and 100 nM PAMmer, where indicated. Aliquots were removed at each 
time point and quenched by the addition of RNA gel loading buffer (95% deionized 
formamide, 0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol, 50 mM EDTA 
(pH 8.0), 0.025% (w/v) SDS). Samples were boiled for 10 min at 95 °C prior to being 
resolved by 12% denaturing PAGE. Reaction products were visualized by phosphorimaging 
and quantified with ImageQuant (GE Healthcare).
RNA cleavage site mapping
A hydrolysis ladder (OH-) was obtained by incubating ~25 nM 5′-radiolabeled λ2 target 
ssRNA in hydrolysis buffer (25 mM CAPS (N-cyclohexyl-3- aminopropanesulfonic acid), 
pH 10.0, 0.25 mM EDTA) at 95 °C for 10 min, before quenching on ice. An RNase T1 
ladder was obtained by incubating ~25 nM 5′-radiolabeled λ2 target ssRNA with 1 Unit 
RNase T1 (NEB) for 5 min at 37 °C in RNase T1 buffer (20 mM sodium citrate, pH 5.0, 1 
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mM EDTA, 2 M urea, 0.1 mg mL-1 yeast tRNA). The reaction was quenched by phenol/
chloroform extraction before adding RNA gel loading buffer. All products were resolved by 
15% denaturing PAGE.
Electrophoretic mobility shift assays
In order to avoid dissociation of the Cas9–gRNA complex at low concentrations during 
target ssRNA binding experiments, binding reactions contained a constant excess of dCas9 
(300 nM), increasing concentrations of sgRNA, and 0.1–1 nM of target ssRNA. The reaction 
buffer was supplemented with 10 μg ml-1 heparin in order to avoid non-specific association 
of apo-dCas9 with target substrates7. Reactions were incubated at 37 °C for 45 min before 
being resolved by 8% native PAGE at 4 °C (0.5× TBE buffer with 5 mM MgCl2). RNA and 
DNA were visualized by phosphorimaging, quantified with ImageQuant (GE Healthcare), 
and analyzed with Kaleidagraph (Synergy Software).
Cas9 Biotin Labeling
To ensure specific labeling at a single residue on Cas9, two naturally occurring cysteine 
residues were mutated to serine (C80S and C574S) and a cysteine point mutant was 
introduced at residue M1. To attach the biotin moiety, 10 μM WT Cas9 or dCas9 was 
reacted with a 50-fold molar excess of EZ-Link® Maleimide-PEG2-Biotin (Thermo 
Scientific) at 25 °C for 2 h. The reaction was quenched by the addition of 10 mM DTT, and 
unreacted Maleimide-PEG2-Biotin was removed using a Bio-Gel® P-6 column (Bio-Rad). 
Labeling was verified using a streptavidin bead binding assay, where 8.5 pmol of 
biotinylated Cas9 or non-biotinylated Cas9 was mixed with either 25 μL streptavidin-
agarose (Pierce Avidin Agarose; Thermo Scientific) or 25 μL streptavidin magnetic beads 
(Dynabeads MyOne Streptavidin C1; Life Technologies). Samples were incubated in Cas9 
reaction buffer at RT for 30 min, followed by three washes with Cas9 reaction buffer and 
elution in boiling SDS-PAGE loading buffer. Elutions were analysed using SDS-PAGE. 
Cas9 M1C biotinylation was also confirmed using mass spectroscopy performed in the QB3/
Chemistry Mass Spectrometry Facility at UC Berkeley. Samples of intact Cas9 proteins 
were analyzed using an Agilent 1200 liquid chromatograph equipped with a Viva C8 (100 
mm × 1.0 mm, 5 μm particles, Restek) analytical column and connected in-line with an LTQ 
Orbitrap XL mass spectrometer (Thermo Fisher Scientific). Mass spectra were recorded in 
the positive ion mode. Mass spectral deconvolution was performed using ProMass software 
(Novatia).
GAPDH mRNA pull-down
HeLa-S3 cell lysates were prepared as previously described33. Total RNA was isolated from 
HeLa-S3 cells using Trizol reagent according to the manufacturer’s instructions (Life 
Technologies). Cas9–sgRNA complexes were reconstituted before pull-down experiments 
by incubating a two-fold molar excess of Cas9 with sgRNA for 10 min at 37 °C in reaction 
buffer. HeLa total RNA (40 μg) or HeLa lysate (~5×106 cells) was added to reaction buffer 
with 40 U RNasin (Promega), PAMmer (5 μM) and the biotin-dCas9 (50 nM):sgRNA (25 
nM) in a total volume of 100 μL and incubated at 37 °C for 1 h. This mixture was then 
added to 25 μL magnetic streptavidin beads (Dynabeads MyOne Streptavidin C1; Life 
Technologies) pre-equilibrated in reaction buffer and agitated at 4 °C for 2 h. Beads were 
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then washed six times with 300 μL wash buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
5mM MgCl2, 0.1% Triton X-100, 5% glycerol, 1mM DTT, 10 μg ml-1 heparin). 
Immobilized RNA was eluted by heating beads at 70 °C in the presence of DEPC-treated 
water and a phenol/chloroform mixture. Eluates were then treated with an equal volume of 
glyoxal loading dye (Life Technologies) and heated at 50 °C for 1 h before separation via 
1% BPTE agarose gel (30 mM Bis-Tris, 10 mM PIPES, 10 mM EDTA, pH 6.5). Northern 
blot transfers were carried out according to Chomczynski et al.34. Following transfer, 
membranes were crosslinked using UV radiation and incubated in pre-hybridization buffer 
(UltraHYB® Ultrasensitive Hybridization Buffer; Life Technologies) for 1 h at 46 °C prior 
to hybridization. Radioactive Northern probes were synthesized using random priming of 
GAPDH and β-actin partial cDNAs (for cDNA primers, see Extended Data Table 2) in the 
presence of [α-32P]-dATP (PerkinElmer), using a Prime-It II Random Primer Labeling kit 
(Agilent Technologies). Hybridization was carried out for 3 h in pre-hybridization buffer at 
46 °C followed by two washes with 2×SSC (300 mM NaCl, 30 mM trisodium citrate, pH 7, 
0.5% (w/v) SDS) for 15 min at 46 °C. Membranes were imaged using a phosphorscreen.
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Extended Data
Extended Data Figure 1. Quantified data for cleavage of ssRNA by Cas9–gRNA in the presence 
of a 19-nt PAMmer
Cleavage assays were conducted as described in the Methods, and the quantified data were 
fit with single-exponential decays. Results from four independent experiments yielded an 
average apparent pseudo-first order cleavage rate constant of 0.032 ± 0.007 min-1. This is 
slower than the rate constant determined previously for ssDNA in the presence of the same 
19-nt PAMmer (7.3 ± 3.2 min-1)7.
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Extended Data Figure 2. RNA cleavage is marginally stimulated by di- and 
trideoxyribonucleotide PAMmers
Cleavage reactions contained ~1 nM 5′-radiolabelled target ssRNA and no PAMmer (left), 
100 nM 18-nt PAMmer (second from left), or 1 mM of the indicated di- or tri-nucleotide 
(remaining lanes). Reaction products were resolved by 12% denaturing polyacrylamide gel 
electrophoresis (PAGE) and visualized by phosphorimaging.
Extended Data Figure 3. Representative binding experiment demonstrating guide-specific 
ssRNA binding with 5′-extended PAMmers
Gel shift assays were conducted as described in the Methods. Binding reactions contained 
Cas9 programmed with λ2 gRNA and either λ2 (on-target), λ3 (off-target) or λ4 (off-target) 
ssRNA in the presence of short cognate PAMmers or cognate PAMmers with complete 5’-
extensions, as indicated. The presence of a cognate 5’-extended PAM-mer abrogates off-
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target binding. Three independent experiments were conducted to produce the data shown in 
Fig. 3b, d.
Extended Data Figure 4. Exploration of RNA cleavage efficiencies and binding specificity using 
PAMmers with variable 5′-extensions
a, Cleavage assays were conducted as described in Methods. Reactions contained Cas9 
programmed with λ2 gRNA and λ2 ssRNA target in the presence of PAMmers with 5’-
extensions of variable length. The ssRNA cleavage efficiency decreases as the PAMmer 
extends further into the target region, as indicated by the fraction RNA cleaved after 1 h. b, 
Binding assays were conducted as described in the Methods, using mostly the same panel of 
5’-extended PAMmers as in (a). Binding reactions contained Cas9 programmed with λ2 
gRNA and either λ2 (on-target) or λ3 (off-target) ssRNA in the presence of cognate 
PAMmers with 5’-extensions of variable length. The binding specificity increases as the 
PAMmer extends further into the target region, as indicated by the fraction of λ3 (off-target) 
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ssRNA bound at 3 nM Cas9-gRNA. PAMmers with 5’ extensions also cause a slight 
reduction in the relative binding affinity of λ2 (on-target) ssRNA.
Extended Data Figure 5. Site-specific biotin labeling of Cas9
a, In order to introduce a single biotin moiety on Cas9, the solvent accessible, non-
conserved N-terminal methionine was mutated to a cysteine (M1C; red text) and the 
naturally occurring cysteine residues were mutated to serine (C80S and C57S; bold text). 
This enabled cysteine-specific labeling with EZ-link® Maleimide-PEG2-biotin through an 
irreversible reaction between the reduced sulfhydryl group of the cysteine and the maleimide 
group present on the biotin label. dCas9 mutations are also indicated in the domain 
schematic. b, Mass spectrometry analysis of the Cas9 biotin labeling reaction confirmed that 
successful biotin labeling only occurs when the M1C mutation is present in the Cys-Free 
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background (C80S, C574S). The mass of the Maleimide-PEG2- biotin reagent is 525.6 Da. 
c, Streptavidin bead binding assay with biotinylated (biot.) or nonbiotinylated (non-biot.) 
Cas9 and streptavidin agarose or streptavidin magnetic beads. Cas9 only remains 
specifically bound to the beads after biotin labeling. d, Cleavage assays were conducted as 
described in the Methods and resolved by denaturing PAGE. Reactions contained 100 nM 
Cas9 programmed with λ2 gRNA and ~1 nM 5′-radiolabelled λ2 dsDNA target. e, 
Quantified cleavage data from triplicate experiments were fit with single-exponential decays 
to calculate the apparent pseudo-first order cleavage rate constants (average ± standard 
deviation). Both Cys-Free and Biotin-M1C Cas9 retain WT activity.
Extended Data Figure 6. RNA-guided Cas9 can utilize chemically modified PAMmers
19-nt PAMmer derivatives containing various chemical modifications on the 5’ and 3’ ends 
(capped) or interspersed still activate Cas9 for cleavage of ssRNA targets. These types of 
modification are often used to increase the in vivo half-life of short oligonucleotides by 
preventing exo- and endonuclease-mediated degradation. Cleavage assays were conducted 
as described in the Methods. PS, phosphorothioate bonds; LNA, locked nucleic acid.
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Extended Data Figure 7. Cas9 programmed with GAPDH-specific gRNAs can pull-down 
GAPDH mRNA in the absence of PAMmer
a, Northern blot showing that, in some cases, Cas9-gRNA is able to pull down detectable 
amounts of GAPDH mRNA from total RNA without requiring a PAMmer. a, Northern blot 
showing that Cas9-gRNA 1 is also able to pull-down quantitative amounts of GAPDH 
mRNA from HeLa cell lysate without requiring a PAMmer. s: standard; v: 2’-OMe-
modified PAMmers.
Extended Data Figure 8. Potential applications of RCas9 for untagged transcript analysis, 
detection, and manipulation
a, Catalytically-active RCas9 could be used to target and cleave RNA, particularly those for 
which RNAi-mediated repression/degradation is not possible. b, Tethering the eukaryotic 
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initiation factor eIF4G to a catalytically inactive dRCas9 targeted to the 5’ untranslated 
region of an mRNA could drive translation. c, dRCas9 tethered to beads could be used to 
specificially isolate RNA or native RNA:protein complexes of interest from cells for 
downstream analysis or assays including identification of bound protein complexes, probing 
of RNA structure under native protein-bound conditions, and enrichment of rare transcripts 
for sequencing analysis. d, dRCas9 tethered to RNA deaminase or N6-mA methylase 
domains could direct site-specific A-to-I editing or methylation or RNA, respectively. e, 
dRCas9 fused to a U1 recruitment domain (arginine- and serine-rich (RS) domain) could be 
programmed to recognize a splicing enhancer site and thereby promote the inclusion of a 
targeted exon. f, dRCas9 tethered to a fluorescent protein such as GFP could be used to 
observe RNA localization and transport in living cells.
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Extended Data Table 1
λ oligonucleotide sequences
*Guide crRNA sequences and complementary DNA target strand sequences are shown in red. PAM sites (5’-NGG-3’) are 
highlighted in yellow on the non-target strand when adjacent to the target sequence or in the PAMmer oligonucleotides.
†
The T7 promoter is indicated in bold (or reverse complement of), as well as 5’ G or GG included in the ssRNA product 
by T7 polymerase.
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NA, not applicable.
‡
sgRNA template obtained from pIDT, subsequently linearised by AflII for run-off transcription.
§
Positions of modifications depicted with asterisks preceding each modified nucleotide in each case (except for PS linkages 
which are depicted between bases)
PS: phosphorothioate bond
LNA: locked nucleic acid
Extended Data Table 2
Oligonucleotides used in the GAPDH mRNA pull-down experiment
*Guide crRNA sequences and complementary DNA target strand sequences are shown in red. PAM sites (5’-NGG-3’) are 
highlighted in yellow on the non-target strand when adjacent to the target sequence or in the PAMmer oligonucleotides.
†
The T7 promoter is indicated in bold (or reverse complement of), as well as 5’ G or GG included in the ssRNA product 
by T7 polymerase. sgRNAs for GAPDH were designed according to Chen, B. et al. Dynamic imaging of genomic loci in 
living human cells by an optimized CRISPR/Cas system. Cell 155, 1479-1491 (2013).
NA, not applicable.
‡
Positions of 2’OMe modifications depicted with asterisks preceding each modified nucleotide in each.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. RNA-guided Cas9 cleaves ssRNA targets in the presence of a short PAM-presenting 
DNA oligonucleotide (PAMmer)
a, Schematic depicting the approach used to target ssRNA for programmable, sequence-
specific cleavage. b, The panel of nucleic acid substrates examined in this study. Substrate 
elements are colored as follows: DNA (grey), RNA (black), guide RNA target sequence 
(red), DNA PAM (yellow), mutated DNA PAM (blue), RNA PAM (orange). c, 
Representative cleavage assay for 5’-radiolabeled nucleic acid substrates using Cas9–gRNA, 
numbered as in (b). d, Cas9–gRNA cleavage site mapping assay for substrate 3. T1 and OH- 
denote RNase T1 and hydrolysis ladders, respectively; the sequence of the target ssRNA is 
shown at right. e, Representative ssRNA cleavage assay in the presence of PAMmers of 
increasing length, numbered as in (b).
O’Connell et al. Page 19
Nature. Author manuscript; available in PMC 2015 June 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. dCas9–gRNA binds ssRNA targets with high affinity in the presence of PAMmers
a, Representative electrophoretic mobility shift assay for binding reactions with dCas9–
gRNA and a panel of 5′-radiolabeled nucleic acid substrates, numbered as in Fig. 1b. b, 
Quantified binding data for substrates 1–4 from (a) fit with standard binding isotherms. 
Measured dissociation constants from three independent experiments (mean ± s.d.) were 
0.036 ± 0.003 nM (1), >100 nM (2), 0.20 ± 0.09 nM (3), and 0.18 ± 0.07 nM (4). c, Relative 
binding data for 1 nM dCas9–gRNA and 5’-radiolabeled ssRNA with a panel of different 
PAMmers. The data are normalized to the amount of binding observed at 1 nM dCas9–
gRNA with a 19-nt PAMmer; error bars represent the standard deviation from three 
independent experiments.
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Figure 3. 5’-extended PAMmers are required for specific target ssRNA binding
a, Cas9 programmed with either λ2-, λ3-, or λ4-targeting gRNAs exhibits sequence-specific 
cleavage of 5’-radiolabeled λ2, λ3, and λ4 target ssRNAs, respectively, in the presence of 
cognate PAMmers. b, dCas9 programmed with a λ2-targeting gRNA exhibits similar 
binding affinity to λ2, λ3, and λ4 target ssRNAs in the presence of cognate PAMmers. 
Dissociation constants from three independent experiments (mean ± s.d.) were 0.20 ± 0.09 
nM (λ2), 0.33 ± 0.14 nM (λ3), and 0.53 ± 0.21 nM (λ4). c, Schematic depicting the 
approach used to restore guide RNA-mediated ssRNA binding specificity, which involves 
5’-extensions to the PAMmer that cover part of the target sequence. d, dCas9 programmed 
with a λ2-targeting gRNA specifically binds the λ2 ssRNA but not λ3 and λ4 ssRNAs in the 
presence of 5’-extended PAMmers. Dissociation constants from three independent 
experiments (mean ± s.d.) were 3.3 ± 1.2 nM (λ2) and >100 nM (λ3 and λ4).
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Figure 4. RNA-guided Cas9 can target non-PAM sites on ssRNA and isolate GAPDH mRNA 
from HeLa cells in a tagless manner
a,Schematic of the approach designed to avoid cleavage of template DNA by targeting non-
PAM sites in the ssRNA target. b, The panel of nucleic acid substrates tested in (c). c, Cas9–
gRNA cleaves ssRNA targets with equal efficiency when the 5’-NGG-3’ of the PAMmer is 
mismatched with the ssRNA. This strategy enables selective cleavage of ssRNA in the 
presence of non-PAM target dsDNA. d, Schematic of the dCas9 RNA pull-down 
experiment. e, GAPDH mRNA transcript isoform 3 shown schematically, with exons 
common to all GAPDH protein-coding transcripts in red and gRNA/PAMmer targets G1-G4 
indicated. f, Northern blot showing that gRNAs and 5’-extended PAMmers enable tagless 
isolation of GAPDH mRNA from HeLa total RNA; β-actin mRNA is shown as a control. g, 
Northern blot showing tagless isolation of GAPDH mRNA from HeLa cell lysate with 
varying 2’-OMe-modified PAMmers. RNase H cleavage is abrogated with v4 and v5 
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PAMmers; β-actin mRNA is shown as a control. h, Sequences of unmodified and modified 
GAPDH PAMmers used in (g); 2’-OMe-modified nucleotides are shown in red.
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